Chronic Kidney Disease - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise

Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

Report on the pharmaceutical and healthcare industry - Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global chronic kidney disease market. This pharma report identifies the key trends shaping and driving the global chronic kidney disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global chronic kidney disease sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

Scope

- Annualized global chronic kidney disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.

- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data split across different phases by mechanism of action and emerging trends. Key classes of mechanism of action phosphate binders, erythropoietin (EPO) activators, nutrition supplements, iron replacement therapy, PTH synthesis inhibitor, Angiotensin Converting Enzyme (ACE) Inhibitor, endothelin antagonist, Angiotensin II Receptor Blocker, Antioxidant Inflammation Modulator, Direct renin inhibitor, IMPDH Inhibitor, Hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor.

- Analysis of the current and future competition in the global chronic kidney disease market. Key market players covered include Reata Pharmaceuticals, Keryx Pharmaceuticals, Cytochroma Inc, Affymax, Ineos Healthcare, Merck & Co Inc, Pfizer, Novartis AG, Amgen and Abbott Plc.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future chronic kidney disease market.

For more information, please visit:

http://www.aarkstore.com/reports/Chronic-Kidney-Disease-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-39189.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise

POST COMMENT

Prostate Health Chronic Obstructive Pulmonary Disease (copd) - Drug Pipeline Analysis And Market Forecasts To 2016 Rome Complete Day Out Points: Places To Sleep, Feast, Fun, And Attractions The Disease Of Drug Addictions What are the Benefits of Winter Wedding Herblife? Boom Shacka Lacka. Fab 4 Shopping Tips to Create Healthy Meal Plans Where To Buy Stylish Spyder Winter Wear Antibacterial All Purpose Cleaners Starting Your Baby Off with a Healthy Diet Lyme Disease - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market When You Should Seek Medical Health Advice For Hair Thinning Looks do matter - enhance them with Denali body kits